R

Rhythm Pharmaceuticals

Commercializes MC4R-targeted therapies for rare obesity

Medical Affairs Lead

Biology & BiotechPosted on Nov 10
Full-timeChiyoda City, Tokyo, JapanNo salary listed

About the Job

Requirements

  • An advanced degree is required.
  • At least 3–5 years of relevant experience in the pharmaceutical and/or biotechnology industry is required.
  • Ability to interpret scientific literature and clinical data, with experience in medical strategy development, publication planning, and congress execution.
  • Track record in generating and disseminating real-world evidence.
  • Strong scientific communication skills with internal and external stakeholders, including confident presentation and facilitation.
  • Familiarity with Japanese regulatory, compliance, and ethical standards governing Medical Affairs activities.
  • Excellent communication and presentation skills in Japanese and English.
  • Proficiency in Microsoft Office, including PowerPoint, Word, and Excel.
  • Ability to travel as necessary, up to 20%.

Responsibilities

  • Contribute to the development of the Japan Medical Affairs plan, aligned with international and local integrated strategies and guided by the Medical Director, Japan.
  • Execute medical tactics and operational activities outlined in the Medical Affairs plan.
  • Plan, organize, and execute advisory boards with the Medical Director, Japan and International Medical Affairs.
  • Build and maintain relationships with Principal Investigators, Key External Experts, and medical societies in Japan.
  • Co-develop and implement the publication plan with International Medical Affairs; ensure timely delivery of abstracts, manuscripts, and congress presentations.
  • Coordinate scientific activities at congresses and ensure alignment with publication and communication strategies.
  • Develop and deliver scientific training and educational content for internal teams, including Scientific Affairs Managers and commercial teams.
  • Provide ongoing scientific and medical support to field teams and cross-functional partners.
  • Support review of promotional and non-promotional materials for scientific accuracy and compliance, and participate in labeling and review meetings as needed.
  • Assist in collaborative research and investigator-initiated studies; contribute to protocol review and scientific oversight.
  • Interpret clinical and real-world data to inform medical insights and evidence-generation priorities.
  • Collaborate with Regulatory, Clinical Development, Market Access, Marketing, and International Medical Affairs to ensure integrated execution of medical initiatives.
  • Ensure compliance with Japanese regulations, company policies, and industry standards, including JPMA and IFPMA principles.
  • Provide medical input for external-facing materials and activities while maintaining separation from promotional decision-making.
  • Strengthen relationships with Key External Experts and drive scientific engagement.
  • Contribute to development of a scientific communication platform and ensure consistency of messaging.
  • Support activities related to gathering access information for rare diseases and pediatric chronic conditions.
  • Support NDA submission activities, including interactions with regulatory authorities and preparation of related documentation.
  • Track progress against Medical Affairs plan deliverables and report metrics to the Medical Director, Japan.
  • Build relationships with patient advocacy groups to increase disease awareness.
  • Perform additional responsibilities as needed to support the team and company objectives.

Desired Qualifications

  • Prior Medical Affairs experience is strongly preferred.
  • Knowledge of rare diseases is a plus.
  • Launch experience is a plus.
  • Experience working for a U.S. company and/or a fast-paced company is a plus.

About the Company

Rhythm Pharmaceuticals

Commercializes MC4R-targeted therapies for rare obesity

Rhythm Pharmaceuticals focuses on developing therapies for rare neuroendocrine genetic obesity disorders, led by IMCIVREE (setmelanotide). IMCIVREE is an MC4R agonist that restores signaling in the MC4R pathway to curb hunger and regulate energy use; it is FDA, EC, and MHRA approved for Bardet-Biedl syndrome and certain POMC/PCSK1/LEPR deficiencies in patients aged 2 and older, with revenue from global sales. The company differentiates itself by pursuing precision medicine for MC4R pathway diseases and advancing additional MC4R programs like bivamelagon and RM-718. Rhythm’s goal is to broaden access to MC4R-targeted therapies for rare patient populations and grow its pipeline toward sustainable commercialization.

Company size
501-1,000
Company stage
IPO
Headquarters
Boston, MA
Founded
2008

Recently Posted Jobs

Explore more opportunities at Rhythm Pharmaceuticals

See more jobs